Bayer

Companies Bayer

News Bayer

• Bayer to acquire Conceptus, Inc.

  Bayer intends to broaden its portfolio in the field of contraception. Thus, Bayer HealthCare LLC has signed a merger agreement with Conceptus, Inc. (CPTS), the California, U.S., based developer of the Essure® procedure, the leading non-surgical permanent birth control method, which is sold in the Un more

• New products create optimism for the future

  2012 was a very successful year for the Bayer Group. “We continued to grow dynamically and achieved our targets for the Group. All the subgroups posted gains in sales and earnings before special items,” said Bayer CEO Dr. Marijn Dekkers at the Financial News Conference in Leverkusen on Thursday. The more

• Bayer’s Riociguat submitted for regulatory approval in the U.S. and EU

  Bayer HealthCare has submitted the oral investigational drug Riociguat to treat patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) for regulatory approval in the United States and in the European Union. “These regulatory submissio more

Publications Bayer

• Cyanuric acid hydrolase: evolutionary innovation by structural concatenation

  Summary The cyanuric acid hydrolase, AtzD, is the founding member of a newly identified family of ring‐opening amidases. We report the first X‐ray structure for this family, which is a novel fold (termed the ‘Toblerone’ fold) that likely evolved via the concatenation of monomers of the trimeric more

• Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy

  Accumulated data from animal models and human cancer patients strongly support the concept that the immune system can identify and control nascent tumor cells in a process called cancer immunosurveillance. In addition, the immune system can also promote tumor progression through chronic inflammati more

• Economic aspects of post‐border weed risk management

  Abstract Aim Decision‐making in weed management involves consideration of limited budgets, long time horizons, conflicting priorities, and as a result, trade‐offs. Economics provides tools that allow these issues to be addressed and is thus integral to management of the risks posed by weeds. O more

Market studies Bayer

• India Pharmaceuticals and Healthcare Report Q3 2012

  BMI View: India's pharmaceutical regulator should drop its requirement for local clinical trials in order for a new medicine to receive approval. The country does not have the necessary number of trained professionals to effectively monitor the costly and timely process. Patients would benefit from more

• Global Active Pharmaceutical Ingredients Market 2011-2015

  TechNavio's analysts forecast the Global Active Pharmaceutical Ingredient market to grow at a CAGR of 7.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel formulation technologies. The Global Active Pharmaceutical Ingredient market ha more

• Poland Pharmaceuticals and Healthcare Report Q3 2012

  BMI View: Despite numerous challenges, we continue to believe Poland is the most attractive pharmaceutical market in Central and Eastern Europe (CEE). While the long-awaited Drug Reimbursement Act introduced in Q112 faced fierce opposition from the public and members of the healthcare profession, an more

Websites Bayer